ASH Addresses Funding, Career Development Gaps in Hematology, With President Robert Negrin, MD

Amid ongoing uncertainty in biomedical research funding and challenges sustaining early-career investigators, the American Society of Hematology (ASH) is working to maintain continuity of research and patient care.1

These efforts include expanded investigator support, global clinical programs, and initiatives aimed at preserving early-career pathways, setting the stage for continued investigational success and community in hematology.1

“Clearly, our most important challenge is doing what we can to help stabilize our field. We are all aware that we are living in challenging times when it comes to biomedical research,” said Robert Negrin, MD, ASH president, in an interview with HCPLive. “We need to show our members that we care, that we are here to help provide resources, mentorship, and support, and that what they do is important and worth continuing.”

In recent years, hematology investigators have faced growing pressure from tighter federal funding cycles, delayed grant timelines, and prolonged paths to research independence, particularly among early-career clinicians balancing clinical responsibilities with investigative work.2

The Fight for Hematology is one way ASH has contributed to career development and advocacy in the hematology community. According to Negrin, the initiative is structured to address multiple pressure points affecting the hematology workforce, including advocacy for research funding stability, visibility for the field’s clinical and scientific contributions, and targeted support for investigators at vulnerable career stages. He emphasized the effort is intended to reinforce existing pathways rather than replace institutional or federal funding mechanisms.1,2

Other pathways include the Hematology Inclusion Pathway, the Women in Hematology Working Group, and the Treating Fairly Research Award, which is given to investigators focused on health outcomes inequities. Negrin shared his major goals during his presidency will be to provide resources, mentorship, and support to the youngest and most vulnerable members of the field.1

These programs are designed to address persistent gaps in retention and advancement across the hematology workforce, particularly among investigators from underrepresented backgrounds or those facing structural barriers to sustained academic careers. Negrin noted society-level initiatives can play a complementary role by offering mentorship, visibility, and early support.

On the international front, Negrin has spent significant time in communities where patient care and clinician support inequities are most prevalent. He highlighted sickle cell disease as a key focus of ASH’s global efforts. An ASH-implemented program in Africa supports newborn screening, early diagnosis, and connects patients with clinicians.

“Although ASH is the American Society of Hematology, it is very much an international organization, and that is something I am proud of.”

For Negrin, recognizing the importance of reaching all communities remains the key to advancing the science.

Despite challenges in research funding and systemic health barriers, hematology has continued to advance. The 67th Annual Meeting and Exposition showcased data on CAR T therapies, next-generation platforms, and bispecific antibody combinations for myeloma and lymphoma, highlighting the field’s scientific momentum even amid broader funding pressures.1

“For me, the key takeaway from the meeting was not the science, although the science was fantastic, and we can certainly talk about that. The key takeaway was the real need for community,” said Negrin. “That came across very strongly, not just for me personally, but for many people who attended the meeting.”

References

1. Negrin R, MD. Looking Ahead to ASH’s 68th Meeting, With President Robert Negrin, MD. HCPLive. January 27, 2026. https://www.hcplive.com/view/looking-ahead-ash-68th-meeting-president-robert-negrin-md. Accessed January 29, 2026.

2. Kuznar W. NIH Research Funding Cuts Would Have Devastating Impact on Hematology. American Health & Drug Benefits. Published 2016. Accessed January 29, 2026. https://www.ahdbonline.com/articles/article-1285

3. Fight4Hematology - Hematology.org. Hematology.org. Published 2026. Accessed January 29, 2026. https://www.hematology.org/advocacy/fight4hematology

‌